Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy C Degnim

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
Seminars in Plastic Surgery|May 30, 2014
Uncommon benign breast abnormalities in adolescentsRebekkah Warren, Amy C Degnim
The Surgical Clinics of North America|May 15, 2007
Prophylactic mastectomyShaheen Zakaria, Amy C Degnim
The Surgical Clinics of North America|March 8, 2013
Surgical management of high-risk breast lesionsAmy C Degnim, Tari A King
Surgical Oncology Clinics of North America|November 15, 2017
When Does Atypical Ductal Hyperplasia Require Surgical Excision?Jennifer M Racz, Amy C Degnim
Surgery|May 17, 2006
Sentinel lymph node biopsy for breast cancer: is two-site injection best?Amy C Degnim, Clive S Grant
Annals of Surgical Oncology|August 27, 2013
Should re-excision lumpectomy rates be a quality measure in breast-conserving surgery?Theresa Schwartz, Amy C Degnim, Jeffrey Landercasper
American Journal of Surgery|March 28, 2008
Safety and technical success of methylene blue dye for lymphatic mapping in breast cancerShaheen Zakaria, Tanya L Hoskin, Amy C Degnim
Annals of Surgical Oncology|August 3, 2017
Lobular Neoplasia and Atypical Ductal Hyperplasia on Core Biopsy: Current Surgical Management RecommendationsJennifer M Racz, Jodi M Carter, Amy C Degnim
The New England Journal of Medicine|March 26, 2015
Atypical hyperplasia of the breastLynn C Hartmann, Amy C Degnim, William D Dupont
American Journal of Surgery|May 12, 2012
Safety of methylene blue dye for lymphatic mapping in patients taking selective serotonin reuptake inhibitorsMiraj G Shah-Khan, Jenna Lovely, Amy C Degnim
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
Seminars in Plastic Surgery|May 30, 2014
Uncommon benign breast abnormalities in adolescentsRebekkah Warren, Amy C Degnim
The Surgical Clinics of North America|May 15, 2007
Prophylactic mastectomyShaheen Zakaria, Amy C Degnim
The Surgical Clinics of North America|March 8, 2013
Surgical management of high-risk breast lesionsAmy C Degnim, Tari A King
Surgical Oncology Clinics of North America|November 15, 2017
When Does Atypical Ductal Hyperplasia Require Surgical Excision?Jennifer M Racz, Amy C Degnim
Surgery|May 17, 2006
Sentinel lymph node biopsy for breast cancer: is two-site injection best?Amy C Degnim, Clive S Grant
Annals of Surgical Oncology|August 27, 2013
Should re-excision lumpectomy rates be a quality measure in breast-conserving surgery?Theresa Schwartz, Amy C Degnim, Jeffrey Landercasper
American Journal of Surgery|March 28, 2008
Safety and technical success of methylene blue dye for lymphatic mapping in breast cancerShaheen Zakaria, Tanya L Hoskin, Amy C Degnim
Annals of Surgical Oncology|August 3, 2017
Lobular Neoplasia and Atypical Ductal Hyperplasia on Core Biopsy: Current Surgical Management RecommendationsJennifer M Racz, Jodi M Carter, Amy C Degnim
The New England Journal of Medicine|March 26, 2015
Atypical hyperplasia of the breastLynn C Hartmann, Amy C Degnim, William D Dupont
American Journal of Surgery|May 12, 2012
Safety of methylene blue dye for lymphatic mapping in patients taking selective serotonin reuptake inhibitorsMiraj G Shah-Khan, Jenna Lovely, Amy C Degnim
Pageof 22